The significance of impaired pancreatic polypeptide and epinephrine responses to hypoglycemia in patients with insulin-dependent diabetes mellitus
- PMID: 3818892
- DOI: 10.1210/jcem-64-3-602
The significance of impaired pancreatic polypeptide and epinephrine responses to hypoglycemia in patients with insulin-dependent diabetes mellitus
Abstract
The impaired epinephrine and glucagon responses to hypoglycemia often found in patients with insulin-dependent diabetes mellitus (IDDM) may be due to autonomic neuropathy. Since the pancreatic polypeptide response to hypoglycemia is mediated by cholinergic mechanisms, we used this response as an indicator of autonomic neuropathy to determine whether deficient epinephrine and glucagon responses in IDDM could be ascribed to an autonomic defect. The relationships between pancreatic polypeptide, epinephrine, and glucagon responses during insulin-induced hypoglycemia were assessed in 18 patients with IDDM who had no overt evidence of autonomic neuropathy, including normal standard cardiovascular reflex tests, and 11 age-matched nondiabetic subjects. All of the diabetic patients had impaired glucagon responses [19 +/- 3 (SEM) vs. 96 +/- 11 pg/ml, peak increment, P less than 0.001]. Ten of the 18 diabetic patients had either impairment of plasma epinephrine or plasma pancreatic polypeptide responses or both to hypoglycemia. Moreover, pancreatic polypeptide responses were significantly correlated with epinephrine responses (r = 0.53, P less than 0.003). There was no association between the plasma glucagon response and the epinephrine (r = 0.02, NS), norepinephrine (r = 0.03, NS), or pancreatic polypeptide (r = 0.35, NS) response. Last, there was no correlation between the plasma hormone responses and the cardiovascular reflex test results. Therefore, the association of impaired plasma pancreatic polypeptide responses with impaired plasma epinephrine responses suggests that the impaired epinephrine responses are due to autonomic neuropathy, whereas the dissociation of plasma glucagon responses with both plasma pancreatic polypeptide and epinephrine responses suggests that the impaired pancreatic alpha-cell response to hypoglycemia is not due to autonomic neuropathy. In addition, the plasma pancreatic polypeptide and epinephrine responses to hypoglycemia appear to be an earlier indicator of underlying autonomic dysfunction than standard cardiovascular reflex tests. Thus, the responses of plasma pancreatic polypeptide and epinephrine to insulin-induced hypoglycemia may be a useful test for the identification of early autonomic neuropathy in IDDM.
Similar articles
-
Subnormal pancreatic polypeptide and epinephrine responses to insulin-induced hypoglycemia identify patients with insulin-dependent diabetes mellitus predisposed to develop overt autonomic neuropathy.Ann Intern Med. 1988 Jan;108(1):54-8. doi: 10.7326/0003-4819-108-1-54. Ann Intern Med. 1988. PMID: 3276265
-
Contribution of autonomic neuropathy to reduced plasma adrenaline responses to hypoglycemia in IDDM: evidence for a nonselective defect.Diabetes. 1997 May;46(5):814-23. doi: 10.2337/diab.46.5.814. Diabetes. 1997. PMID: 9133549
-
Hypoglycemia-induced autonomic failure in IDDM is specific for stimulus of hypoglycemia and is not attributable to prior autonomic activation.Diabetes. 1994 Jun;43(6):809-18. doi: 10.2337/diab.43.6.809. Diabetes. 1994. PMID: 8194668
-
Epinephrine secretion, hypoglycemia unawareness, and diabetic autonomic neuropathy.Ann Intern Med. 1994 Mar 15;120(6):512-7. doi: 10.7326/0003-4819-120-6-199403150-00011. Ann Intern Med. 1994. PMID: 8311375 Review.
-
Glucose counterregulation in diabetic autonomic neuropathy.Clin Physiol. 1985;5 Suppl 5:66-71. Clin Physiol. 1985. PMID: 2870835 Review. No abstract available.
Cited by
-
Utility of the plasma pancreatic polypeptide response to modified sham feeding in diabetic gastroenteropathy and non-ulcer dyspepsia.Neurogastroenterol Motil. 2020 Feb;32(2):e13744. doi: 10.1111/nmo.13744. Epub 2019 Oct 22. Neurogastroenterol Motil. 2020. PMID: 31642143 Free PMC article.
-
The endocrine system in diabetes mellitus.Endocrine. 2002 Jul;18(2):105-19. doi: 10.1385/ENDO:18:2:105. Endocrine. 2002. PMID: 12374457 Review.
-
GIP contributes to islet trihormonal abnormalities in type 2 diabetes.J Clin Endocrinol Metab. 2014 Jul;99(7):2477-85. doi: 10.1210/jc.2013-3994. Epub 2014 Apr 8. J Clin Endocrinol Metab. 2014. PMID: 24712564 Free PMC article. Clinical Trial.
-
Effects of chronic sodium salicylate feeding on the impaired glucagon and epinephrine responses to insulin-induced hypoglycaemia in streptozotocin diabetic rats.Diabetologia. 1989 Jan;32(1):61-6. doi: 10.1007/BF00265406. Diabetologia. 1989. PMID: 2707517
-
Basal and nutrient-stimulated pancreatic and gastrointestinal hormone concentrations in type-1-diabetic patients after successful combined pancreas and kidney transplantation.Clin Investig. 1992 Jan;70(1):40-8. doi: 10.1007/BF00422937. Clin Investig. 1992. PMID: 1600330
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous